Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.

Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.

Data from an open-label trial showed that foralumab treatment eased fatigue and lessened disability for some people with ...

In parallel with these encouraging results, Tiziana Life Sciences has initiated a randomized, double-blind, placebo-controlled Phase 2 clinical trial to further assess the efficacy and safety of nasal ...

For five years, the clinical-stage pharmaceutical company has developed Enbumyst, a nasal spray intended to remove excess ...

Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.

A new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one ...

An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

It’s the best bottle of bug spray we found after testing over 25 repellents and talking to everyone from the EPA to the American Mosquito Control Association. This EPA-approved picaridin formula ...

Credit: Amnaj Khetsamtip/Shutterstock. Tiziana Life Sciences has announced the commencement of dosing in the fourth clinical site of the company’s Phase II trial of intranasal foralumab for non-active ...

Tiziana’s innovative nasal approach has the potential to provide an improvement in efficacy as well as safety and tolerability compared to intravenous (IV) delivery. Tiziana’s lead candidate, ...